UCP2 and PRMT1 are key prognostic markers for lung carcinoma patients

Corina T. Madreiter-Sokolowski, B. Györffy, Christiane Klec, Armin A. Sokolowski, Rene Rost, Markus Waldeck-Weiermair, Roland Malli, Wolfgang F. Graier

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Cancer cells have developed unique strategies to meet their high energy demand. Therefore, they have established a setting of Ca2+-triggered high mitochondrial activity. But mitochondrial Ca2+ uptake has to be strictly controlled to avoid mitochondrial Ca2+ overload that would cause apoptotic cell death. Methylation by protein arginine methyl transferase 1 (PRMT1) desensitizes the mitochondrial Ca2+ uptake machinery and reduces mitochondrial Ca2+ accumulation in cancer cells. In case of PRMT1- driven methylation, proper mitochondrial Ca2+ uptake is reestablished by increased activity of uncoupling protein 2 (UCP2), pointing to an importance of these proteins for cancer cell survival and activity. Accordingly, in this study we investigated the impact of UCP2 and PRMT1 on the fate of human lung cancer cells (A549, Calu-3 and H1299) as well as on patients suffering from lung carcinoma. We show that combined overexpression of UCP2 and PRMT1 significantly enhances viability, proliferation as well as mitochondrial respiration. In line with these findings, the overall survival probability of lung carcinoma patients with high mRNA expression levels of UCP2 and PRMT1 is strongly reduced. Furthermore, analysis via The Cancer Genome Atlas (TCGA) reveals upregulation of both proteins, UCP2 and PRMT1, as common feature of various cancer types. These findings suggest that proper mitochondrial Ca2+ uptake is essential for devastating tumor growth, and highlight the importance of a tightly controlled mitochondrial Ca2+ uptake to ensure proper ATP biosynthesis while avoiding dangerous mitochondrial Ca2+ overload. By that, the study unveils proteins of the mitochondrial Ca2+ uptake as potential targets for cancer treatment.

Original languageEnglish
Pages (from-to)80278-80285
Number of pages8
JournalOncotarget
Volume8
Issue number46
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Transferases
Arginine
Carcinoma
Lung
Proteins
Neoplasms
Methylation
Uncoupling Protein 2
Atlases
Mitochondrial Proteins
Lung Neoplasms
Cell Survival
Respiration
Cell Death
Up-Regulation
Adenosine Triphosphate
Genome
Messenger RNA
Survival
Growth

Keywords

  • Ca controls respiration
  • Lung cancer cell proliferation
  • Mitochondria
  • Protein arginine methyltransferase 1
  • Uncoupling protein 2

ASJC Scopus subject areas

  • Oncology

Cite this

Madreiter-Sokolowski, C. T., Györffy, B., Klec, C., Sokolowski, A. A., Rost, R., Waldeck-Weiermair, M., ... Graier, W. F. (2017). UCP2 and PRMT1 are key prognostic markers for lung carcinoma patients. Oncotarget, 8(46), 80278-80285. https://doi.org/10.18632/oncotarget.20571

UCP2 and PRMT1 are key prognostic markers for lung carcinoma patients. / Madreiter-Sokolowski, Corina T.; Györffy, B.; Klec, Christiane; Sokolowski, Armin A.; Rost, Rene; Waldeck-Weiermair, Markus; Malli, Roland; Graier, Wolfgang F.

In: Oncotarget, Vol. 8, No. 46, 01.01.2017, p. 80278-80285.

Research output: Contribution to journalArticle

Madreiter-Sokolowski, CT, Györffy, B, Klec, C, Sokolowski, AA, Rost, R, Waldeck-Weiermair, M, Malli, R & Graier, WF 2017, 'UCP2 and PRMT1 are key prognostic markers for lung carcinoma patients', Oncotarget, vol. 8, no. 46, pp. 80278-80285. https://doi.org/10.18632/oncotarget.20571
Madreiter-Sokolowski CT, Györffy B, Klec C, Sokolowski AA, Rost R, Waldeck-Weiermair M et al. UCP2 and PRMT1 are key prognostic markers for lung carcinoma patients. Oncotarget. 2017 Jan 1;8(46):80278-80285. https://doi.org/10.18632/oncotarget.20571
Madreiter-Sokolowski, Corina T. ; Györffy, B. ; Klec, Christiane ; Sokolowski, Armin A. ; Rost, Rene ; Waldeck-Weiermair, Markus ; Malli, Roland ; Graier, Wolfgang F. / UCP2 and PRMT1 are key prognostic markers for lung carcinoma patients. In: Oncotarget. 2017 ; Vol. 8, No. 46. pp. 80278-80285.
@article{b20dfa8f740844c3b85c98348a5ad395,
title = "UCP2 and PRMT1 are key prognostic markers for lung carcinoma patients",
abstract = "Cancer cells have developed unique strategies to meet their high energy demand. Therefore, they have established a setting of Ca2+-triggered high mitochondrial activity. But mitochondrial Ca2+ uptake has to be strictly controlled to avoid mitochondrial Ca2+ overload that would cause apoptotic cell death. Methylation by protein arginine methyl transferase 1 (PRMT1) desensitizes the mitochondrial Ca2+ uptake machinery and reduces mitochondrial Ca2+ accumulation in cancer cells. In case of PRMT1- driven methylation, proper mitochondrial Ca2+ uptake is reestablished by increased activity of uncoupling protein 2 (UCP2), pointing to an importance of these proteins for cancer cell survival and activity. Accordingly, in this study we investigated the impact of UCP2 and PRMT1 on the fate of human lung cancer cells (A549, Calu-3 and H1299) as well as on patients suffering from lung carcinoma. We show that combined overexpression of UCP2 and PRMT1 significantly enhances viability, proliferation as well as mitochondrial respiration. In line with these findings, the overall survival probability of lung carcinoma patients with high mRNA expression levels of UCP2 and PRMT1 is strongly reduced. Furthermore, analysis via The Cancer Genome Atlas (TCGA) reveals upregulation of both proteins, UCP2 and PRMT1, as common feature of various cancer types. These findings suggest that proper mitochondrial Ca2+ uptake is essential for devastating tumor growth, and highlight the importance of a tightly controlled mitochondrial Ca2+ uptake to ensure proper ATP biosynthesis while avoiding dangerous mitochondrial Ca2+ overload. By that, the study unveils proteins of the mitochondrial Ca2+ uptake as potential targets for cancer treatment.",
keywords = "Ca controls respiration, Lung cancer cell proliferation, Mitochondria, Protein arginine methyltransferase 1, Uncoupling protein 2",
author = "Madreiter-Sokolowski, {Corina T.} and B. Gy{\"o}rffy and Christiane Klec and Sokolowski, {Armin A.} and Rene Rost and Markus Waldeck-Weiermair and Roland Malli and Graier, {Wolfgang F.}",
year = "2017",
month = "1",
day = "1",
doi = "10.18632/oncotarget.20571",
language = "English",
volume = "8",
pages = "80278--80285",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "46",

}

TY - JOUR

T1 - UCP2 and PRMT1 are key prognostic markers for lung carcinoma patients

AU - Madreiter-Sokolowski, Corina T.

AU - Györffy, B.

AU - Klec, Christiane

AU - Sokolowski, Armin A.

AU - Rost, Rene

AU - Waldeck-Weiermair, Markus

AU - Malli, Roland

AU - Graier, Wolfgang F.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Cancer cells have developed unique strategies to meet their high energy demand. Therefore, they have established a setting of Ca2+-triggered high mitochondrial activity. But mitochondrial Ca2+ uptake has to be strictly controlled to avoid mitochondrial Ca2+ overload that would cause apoptotic cell death. Methylation by protein arginine methyl transferase 1 (PRMT1) desensitizes the mitochondrial Ca2+ uptake machinery and reduces mitochondrial Ca2+ accumulation in cancer cells. In case of PRMT1- driven methylation, proper mitochondrial Ca2+ uptake is reestablished by increased activity of uncoupling protein 2 (UCP2), pointing to an importance of these proteins for cancer cell survival and activity. Accordingly, in this study we investigated the impact of UCP2 and PRMT1 on the fate of human lung cancer cells (A549, Calu-3 and H1299) as well as on patients suffering from lung carcinoma. We show that combined overexpression of UCP2 and PRMT1 significantly enhances viability, proliferation as well as mitochondrial respiration. In line with these findings, the overall survival probability of lung carcinoma patients with high mRNA expression levels of UCP2 and PRMT1 is strongly reduced. Furthermore, analysis via The Cancer Genome Atlas (TCGA) reveals upregulation of both proteins, UCP2 and PRMT1, as common feature of various cancer types. These findings suggest that proper mitochondrial Ca2+ uptake is essential for devastating tumor growth, and highlight the importance of a tightly controlled mitochondrial Ca2+ uptake to ensure proper ATP biosynthesis while avoiding dangerous mitochondrial Ca2+ overload. By that, the study unveils proteins of the mitochondrial Ca2+ uptake as potential targets for cancer treatment.

AB - Cancer cells have developed unique strategies to meet their high energy demand. Therefore, they have established a setting of Ca2+-triggered high mitochondrial activity. But mitochondrial Ca2+ uptake has to be strictly controlled to avoid mitochondrial Ca2+ overload that would cause apoptotic cell death. Methylation by protein arginine methyl transferase 1 (PRMT1) desensitizes the mitochondrial Ca2+ uptake machinery and reduces mitochondrial Ca2+ accumulation in cancer cells. In case of PRMT1- driven methylation, proper mitochondrial Ca2+ uptake is reestablished by increased activity of uncoupling protein 2 (UCP2), pointing to an importance of these proteins for cancer cell survival and activity. Accordingly, in this study we investigated the impact of UCP2 and PRMT1 on the fate of human lung cancer cells (A549, Calu-3 and H1299) as well as on patients suffering from lung carcinoma. We show that combined overexpression of UCP2 and PRMT1 significantly enhances viability, proliferation as well as mitochondrial respiration. In line with these findings, the overall survival probability of lung carcinoma patients with high mRNA expression levels of UCP2 and PRMT1 is strongly reduced. Furthermore, analysis via The Cancer Genome Atlas (TCGA) reveals upregulation of both proteins, UCP2 and PRMT1, as common feature of various cancer types. These findings suggest that proper mitochondrial Ca2+ uptake is essential for devastating tumor growth, and highlight the importance of a tightly controlled mitochondrial Ca2+ uptake to ensure proper ATP biosynthesis while avoiding dangerous mitochondrial Ca2+ overload. By that, the study unveils proteins of the mitochondrial Ca2+ uptake as potential targets for cancer treatment.

KW - Ca controls respiration

KW - Lung cancer cell proliferation

KW - Mitochondria

KW - Protein arginine methyltransferase 1

KW - Uncoupling protein 2

UR - http://www.scopus.com/inward/record.url?scp=85030623679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030623679&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.20571

DO - 10.18632/oncotarget.20571

M3 - Article

VL - 8

SP - 80278

EP - 80285

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 46

ER -